Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Scotia clarifies questions regarding its PLA dossier for Tarabetic

Nov. 8, 1996

Novo Nordisk/Takeda diabetes collaboration

Nov. 8, 1996

Phase IIb/IIc trials with CholestaGel

Nov. 8, 1996

Federal Circuit affirms patent judgment for Amgen against Genetics Institute

Nov. 8, 1996

Squalene synthase inhibitors reported by RPR

Nov. 8, 1996

Yamanouchi discloses hypocholesterolemic agents

Nov. 8, 1996

NPS and SKB extend osteoporosis research collaboration

Nov. 8, 1996

Interpore and Quantic to develop cartilage repair product

Nov. 8, 1996

TheraTech's testosterone patch now being tested in women with sexual dysfunction

Nov. 1, 1996

New, more convenient testosterone transdermal patch submitted for approval

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.